Jandeleit-Dahm K - Search Results

1

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis.

Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, Cooper ME, Kantharidis P. Wang B, et al. J Am Soc Nephrol. 2012 Feb;23(2):252-65. doi: 10.1681/ASN.2011010055. Epub 2011 Nov 17. J Am Soc Nephrol. 2012. PMID: 22095944 Free PMC article.

2

Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy.

Jandeleit-Dahm K, Cao Z, Cox AJ, Kelly DJ, Gilbert RE, Cooper ME. Jandeleit-Dahm K, et al. Kidney Int Suppl. 1999 Jul;71:S31-6. doi: 10.1046/j.1523-1755.1999.07109.x. Kidney Int Suppl. 1999. PMID: 10412733 Free article. Review.

3

SPARC gene expression is increased in diabetes-related mesenteric vascular hypertrophy.

Jandeleit-Dahm K, Rumble J, Cox AJ, Kelly DJ, Dziadek M, Cooper ME, Gilbert RE. Jandeleit-Dahm K, et al. Microvasc Res. 2000 Jan;59(1):61-71. doi: 10.1006/mvre.1999.2189. Microvasc Res. 2000. PMID: 10625572

4

Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.

Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahm K, Kelly DJ, Gilbert RE. Cao Z, et al. Hypertension. 2000 Oct;36(4):561-8. doi: 10.1161/01.hyp.36.4.561. Hypertension. 2000. PMID: 11040236

5

Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.

Jandeleit-Dahm K, Hannan KM, Farrelly CA, Allen TJ, Rumble JR, Gilbert RE, Cooper ME, Little PJ. Jandeleit-Dahm K, et al. Circ Res. 2000 Dec 8;87(12):1133-40. doi: 10.1161/01.res.87.12.1133. Circ Res. 2000. PMID: 11110770

6

Is there a role for endothelin antagonists in diabetic renal disease?

Jandeleit-Dahm K, Allen TJ, Youssef S, Gilbert RE, Cooper ME. Jandeleit-Dahm K, et al. Diabetes Obes Metab. 2000 Jan;2(1):15-24. doi: 10.1046/j.1463-1326.2000.00045.x. Diabetes Obes Metab. 2000. PMID: 11220349 Review. No abstract available.

7

Mechanisms of diabetic vasculopathy: an overview.

Cooper ME, Bonnet F, Oldfield M, Jandeleit-Dahm K. Cooper ME, et al. Am J Hypertens. 2001 May;14(5 Pt 1):475-86. doi: 10.1016/s0895-7061(00)01323-6. Am J Hypertens. 2001. PMID: 11368471 Review.

8

Hypertension and diabetes.

Jandeleit-Dahm K, Cooper ME. Jandeleit-Dahm K, et al. Curr Opin Nephrol Hypertens. 2002 Mar;11(2):221-8. doi: 10.1097/00041552-200203000-00014. Curr Opin Nephrol Hypertens. 2002. PMID: 11856916 Review.

9

Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice.

Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ. Candido R, et al. Circulation. 2002 Jul 9;106(2):246-53. doi: 10.1161/01.cir.0000021122.63813.32. Circulation. 2002. PMID: 12105166

10

Imatinib attenuates diabetes-associated atherosclerosis.

Lassila M, Allen TJ, Cao Z, Thallas V, Jandeleit-Dahm KA, Candido R, Cooper ME. Lassila M, et al. Arterioscler Thromb Vasc Biol. 2004 May;24(5):935-42. doi: 10.1161/01.ATV.0000124105.39900.db. Epub 2004 Feb 26. Arterioscler Thromb Vasc Biol. 2004. PMID: 14988091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

172 results

Search Page

Filters